Investment analysts at Bank of America Corp. initiated coverage on shares of Henry Schein Inc. (NASDAQ:HSIC) in a research note issued on Monday. The firm set a “buy” rating on the stock.
Several other research firms also recently commented on HSIC. Credit Suisse Group AG reaffirmed a “hold” rating on shares of Henry Schein in a report on Saturday, June 4th. Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Tuesday, July 5th. Seven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $155.37.
Henry Schein (NASDAQ:HSIC) opened at 158.86 on Monday. Henry Schein has a 12-month low of $127.16 and a 12-month high of $183.00. The company has a market capitalization of $12.99 billion, a price-to-earnings ratio of 26.91 and a beta of 1.03. The firm has a 50-day moving average of $167.71 and a 200 day moving average of $171.19.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/12/henry-schein-inc-hsic-research-coverage-started-at-bank-of-america-corp.html
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Thursday, August 4th. The company reported $1.64 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.63 by $0.01. The company earned $2.87 billion during the quarter, compared to analyst estimates of $2.85 billion. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The firm’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.46 earnings per share. Analysts expect that Henry Schein will post $6.57 EPS for the current fiscal year.
In related news, Director Paul Brons sold 3,381 shares of the company’s stock in a transaction that occurred on Monday, August 29th. The shares were sold at an average price of $164.03, for a total value of $554,585.43. Following the transaction, the director now directly owns 13,715 shares in the company, valued at $2,249,671.45. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.27% of the stock is currently owned by corporate insiders.
Several hedge funds and other institutional investors recently bought and sold shares of HSIC. Stifel Financial Corp boosted its position in Henry Schein by 298.9% in the fourth quarter. Stifel Financial Corp now owns 120,525 shares of the company’s stock valued at $15,711,000 after buying an additional 90,311 shares during the period. Nomura Asset Management Co. Ltd. boosted its position in Henry Schein by 1.4% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 30,065 shares of the company’s stock valued at $4,756,000 after buying an additional 401 shares during the period. Norges Bank bought a new position in Henry Schein during the fourth quarter valued at $115,454,000. Chevy Chase Trust Holdings Inc. boosted its position in Henry Schein by 37.1% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 215,283 shares of the company’s stock valued at $37,164,000 after buying an additional 58,272 shares during the period. Finally, Alecta Pensionsforsakring Omsesidigt bought a new position in Henry Schein during the first quarter valued at $434,510,000. Institutional investors own 92.00% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Ratings for Henry Schein Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Henry Schein Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.